Methods of terminal sterilization of fibrinogen
AssigneeElan Drug Delivery Limited
InventorsJaap Kampinga, Robert A. Alcock
Life of this patent
Estimating the term…
Loading patent…
AssigneeElan Drug Delivery Limited
InventorsJaap Kampinga, Robert A. Alcock
Estimating the term…
The invention relates to methods of sterilizing biologically active products, particularly therapeutic or prophylactic products and the compositions obtained thereby. The methods include obtaining a dried sample containing an amount of trehalose sufficient to render heat stability to the product and exposing the dried sample to heating conditions at a temperature and for a duration sufficient to substantially inactivate viruses, especially non-lipid encapsulated viruses. The drying methods include both ambient drying conditions and lyophilization. The heating conditions include any known in the art and cover a wide range of temperatures and heating times. The compositions obtained contain stable products and do not contain measurable infectious virus, particularly parvovirus.
A method of terminal sterilization of a biologically active product suitable for sterile administration to an individual comprising:
A composition comprising a terminally sterilized biologically active product suitable for sterile administration to an individual, wherein the product is fibrinogen, and further wherein the product is prepared by heating a dried sample comprising the biologically active product and an amount of α-D-glucopyranosyl-α-D-glucopyranoside sufficient to render heat stability to the product, at a temperature and for a duration sufficient to inactivate parvovirus.
Dependencies are inferred from the claim text.